Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans

OBJECTIVE— Fibroblast growth factor 21 (FGF21) is a metabolic regulator with multiple beneficial effects on glucose homeostasis and insulin sensitivity in animal models. This study aimed to investigate the relationship between its serum levels and various cardiometabolic parameters in humans. RESEAR...

全面介绍

Saved in:
书目详细资料
Main Authors: Xinmei Zhang, Dennis C.Y. Yeung, Michal Karpíšek, David Stejskal, Zhiguang Zhou, Feng Liu, Rachel L.C. Wong, Wing‐Sun Chow, Annette W.K. Tso, Karen S.L. Lam, Aimin Xu
格式: Artigo
语言:英语
出版: 2008
在线阅读:https://doi.org/10.2337/db07-1476
标签: 添加标签
没有标签, 成为第一个标记此记录!